National Comprehensive Cancer Network

|
|
|
|
For Patients
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

NCCN 2nd Annual Congress Hematologic Malignancies

Clinicians

Register Online

Congress Information

Program Overview

Educational Objectives

Conference Agenda

Intended Audience

Accreditation

Accommodations

Commercial Support

Exhibiting

Refer a Friend


Go back to previous page

 

 

     
 

Educational Objectives

Following this program, participants should be able to:

  • List the appropriate pathology techniques for diagnosis and prognostic modeling for patients with hematologic malignancies
  • Identify the available therapeutic options for acute myeloid leukemia, chronic myelogenous leukemia, systemic light chain amyloidosis, multiple myeloma, mantle cell lymphoma, and low-grade lymphoma
  • Describe the clinically relevant subtypes of myelodysplastic syndromes and risk assessment with respect to their roles in selecting therapy
  • Define best practices for the management of supportive care issues including fever and neutropenia, thrombocytopenia, bone complications, and iron overload
  • Summarize the management of tumor lysis syndrome